Research Peptide Prices UK: What You'll Pay in 2026

Research Peptide Prices in the UK: What Drives the Cost in 2026

Two vials of Retatrutide, both labelled ≥99% purity, can sit £40 apart in price on the same afternoon. That gap is not random — it almost always traces back to one thing: whether the purity claim has been verified by an independent laboratory or simply printed on a label. Understanding that distinction is worth more than any discount code.

This guide covers the main peptides stocked by Negra Peptides, what you can expect to pay at 2026 prices, and the factors that genuinely shift the number in your basket.

---

What You'll Pay: Indicative Price Ranges

The figures below reflect typical retail pricing for research-grade, lyophilised peptides from Negra Peptides in 2026. They are indicative — batch size, compound complexity, and testing overhead all affect the final price, and stock levels can move pricing within these bands.

Metabolic and Triple/Dual Agonist Peptides

These are the more technically demanding compounds to synthesise at high purity, and pricing reflects that.

• Retatrutide (GIP / GLP-1 / glucagon triple agonist): typically £59–£120 depending on vial size. Larger research quantities bring the per-mg cost down noticeably.
• Tirzepatide (GIP / GLP-1 dual agonist): typically £69–£110 across common size options.

Both are longer-chain peptides. Achieving ≥99% purity on a structurally complex compound means more rigorous synthesis and a higher batch rejection rate at the testing stage — costs that are passed on, but worth paying if analytical certainty matters to your work.

Body Protection and Recovery Compounds

• BPC-157 (10mg): typically £20–£28. A well-established compound with a settled supply chain, which keeps pricing more stable than newer entries to the market.
• TB-500 (Thymosin beta-4 fragment, 10mg): typically £25–£35. Slightly more complex to source at verified purity than BPC-157, and that is reflected in the modest premium.

Smaller Research Compounds

• KPV (10mg): typically £20–£28. A short-chain tripeptide; lower synthesis cost but still requires proper identity verification before it is worth using.
• DSIP (5mg): typically £14–£20. The lower figure reflects the smaller mass per vial, not a quality shortcut.
• Melanotan 1 (10mg): typically £18–£25.

---

What Drives the Price Up (or Down)

Third-Party Testing

This is the single biggest legitimate cost factor. Sending each batch to an independent laboratory for identity and purity analysis — and publishing the resulting certificate — costs money that a supplier cutting corners simply does not spend. That overhead sits inside the price you pay, and it is the overhead that matters most.

Negra Peptides batch-tests every product and publishes the certificates of analysis (CoAs). If a supplier you are comparing against cannot show you a CoA tied to a specific batch number and a named laboratory, the lower price is not a saving — it is a transfer of risk onto you.

Peptide Chain Length and Complexity

Longer peptides are harder to synthesise cleanly. Each additional amino acid introduces more opportunity for truncation, deletion sequences, or oxidation. Reaching ≥99% purity on a 39-residue molecule costs more than reaching the same threshold on a 3-residue tripeptide like KPV. Most of the price difference between product categories maps directly onto this reality.

Lyophilisation

All serious research suppliers sell peptides in lyophilised (freeze-dried) form rather than in solution. Lyophilisation extends shelf life and maintains stability in transit — but it adds a processing step that some cheaper suppliers skip. A peptide sold pre-dissolved at a conspicuously lower price is worth questioning before you order.

Vial Size and Volume

For compounds like Retatrutide and Tirzepatide that come in multiple sizes, the per-mg cost typically falls as you move to larger quantities. If your protocol runs over several weeks or months, comparing unit cost across available sizes before defaulting to the smallest option is straightforward and often saves money.

UK Dispatch vs. Overseas Sourcing

Ordering from a UK-based supplier means no customs delays, no import duties, and a consistent transit time. Overseas suppliers may look cheaper at face value, but customs seizure risk, unpredictable lead times, and the practical difficulty of chasing a batch CoA across jurisdictions all add hidden cost. Negra Peptides dispatches from the UK, which removes those variables entirely.

---

Red Flags That Make a Cheap Price Expensive

• No batch-specific CoA, or a CoA with no laboratory name, accreditation reference, or date.
• Peptides sold in solution rather than lyophilised powder.
• No "for research use only" framing — suggests the supplier is not operating within appropriate UK guidelines.
• No UK address or traceable contact detail. Returns and queries become difficult fast.
• Per-mg pricing dramatically below the ranges above. Peptide synthesis at genuine ≥99% purity has a floor cost; below it, something has been compromised.

---

A Note on Value vs. Price

For laboratory research, the cost of a contaminated or mis-identified compound is not just the money spent on the vial — it is the experimental time lost, the integrity of the data, and potentially the credibility of the work itself. The pricing premium for a third-party tested, batch-traceable UK supplier is modest against that risk.

At 2026 prices, a properly tested research peptide from a UK source typically runs between £15 and £120 depending on compound and quantity. That is a reasonable range for material you can actually rely on.

---

If you want to check current stock, compare sizes, or talk through which compound suits your research requirements, get in touch with Negra Peptides directly — the team is easy to reach and will give you a straight answer without any sales pressure.